Monopar Therapeutics
MNPR
MNPR
11 hedge funds and large institutions have $323K invested in Monopar Therapeutics in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
31% less capital invested
Capital invested by funds: $471K → $323K (-$148K)
Holders
11
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$32.6K | |
| 2 | +$7K | |
| 3 | +$4.5K | |
| 4 |
JPMorgan Chase & Co
New York
|
+$3K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$1.35K |